Related Experiment Video
Updated: Aug 10, 2026

A High-performance Liquid Chromatography Measurement of Kynurenine and Kynurenic Acid: Relating Biochemistry to Cognition and Sleep in Rats
Published on: August 19, 2018
Brain phenylalanine concentration in the management of adults with phenylketonuria
1Children's Hospital of Los Angeles, Division of Medical Genetics and Neuroradiology 90027, USA.
Insights
Measuring brain phenylalanine levels in phenylketonuria (PKU) patients may improve clinical decisions. Exceptional patients with high blood phenylalanine but good IQs had lower brain levels, suggesting brain measurement is key for managing PKU.
Area of Science:
- Biochemistry
- Neurology
- Genetics
Background:
- Newborn screening and phenylalanine-restricted diets enable normal development in most phenylketonuria (PKU) patients.
- Dietary recommendations for PKU vary, especially for adults, due to factors like quality of life, cost, and genetics.
- Current methods like molecular analysis and MRI lack clear correlations for PKU management.
Purpose of the Study:
- To investigate the direct measurement of brain phenylalanine levels as a tool for clinical decision-making in PKU management.
- To explore the relationship between blood and brain phenylalanine concentrations in PKU patients.
Main Methods:
- Simultaneous measurement of blood and brain phenylalanine levels in 21 PKU subjects.
- Inclusion of randomly selected patients, clinically examined patients, and exceptional patients with high IQs despite high historical blood phenylalanine levels.
Main Results:
- A generally poor correlation was observed between blood and brain phenylalanine concentrations.
- Four exceptional patients with high IQs and high historical blood phenylalanine showed relatively low brain phenylalanine levels.
- This suggests that low brain phenylalanine levels may explain good clinical status in some PKU patients.
Conclusions:
- Direct measurement of brain phenylalanine concentration appears useful for managing PKU patients.
- This approach may offer better insights than blood levels alone, especially for adults and those with historical dietary non-adherence.
Abstract:
Diagnosis by newborn screening and the implementation of a phenylalanine-restricted diet have resulted in normal neurological development in approximately 10,000 persons with phenylketonuria (PKU) in the United States. While it is accepted that a phenylalanine-restricted diet is necessary in childhood, the recommended concentration of phenylalanine in the blood varies. Clinicians now must make recommendations for adults with PKU who probably tolerate higher levels of phenylalanine than children. This factor, quality of life issues, the expense of the diet, and varying genetic and socioeconomic backgrounds, make the choice of dietary recommendations difficult. Molecular analysis of the mutations in PKU has provided insight but has not resulted in clear recommendations for phenylalanine concentration in the blood. Magnetic resonance imaging has provided the recognition that white-matter changes are present in PKU. However, owing to poor correlation of white-matter changes with clinical factors, analysis of white-matter changes has not proved useful. We hypothesize that measurement of brain phenylalanine directly will aid in clinical decision making. Twenty-one subjects with PKU had blood and brain phenylalanine measured simultaneously. Fifteen were randomly selected, 2 were examined for clinical reasons and 4 exceptional patients were chosen because they had maintained high IQs, despite having high historic blood concentrations and having been off the diet for at least 10 years. The correlation of blood and brain phenylalanine is in general poor. However, the four exceptional patients all had relatively low concentrations of phenylalanine in their brains compared to their blood. We suggest that their good clinical status, despite high historic blood levels, is due to their comparatively low brain levels of phenylalanine. We further suggest that measurement of brain phenylalanine concentration is useful in the management of PKU patients.
More Related Videos
10:38Simultaneous Quantification of Selected Kynurenines Analyzed by Liquid Chromatography-Mass Spectrometry in Medium Collected from Cancer Cell Cultures
Published on: May 9, 2020
14:39Semi-Targeted Ultra-High-Performance Chromatography Coupled to Mass Spectrometry Analysis of Phenolic Metabolites in Plasma of Elderly Adults
Published on: April 22, 2022
Related Concept Videos
Overview of Protein Metabolism
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Inborn Errors of Metabolism
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Drug Excretion